Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric blepharokeratoconjunctivitis treatment strategy study
ChiCTR1800015604Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tobramycin and dexamethasone in blepharokeratoconjunctivitis (BKC) (4 arms), sponsored by Peking University Third Hospital. Primary endpoints: Visual acuity, Intraocular pressure and 6 more. Started Apr 2018; status: recruiting.
02
Drugs
tobramycindexamethasone
03
Conditions
blepharokeratoconjunctivitis (BKC)
Beyond the preview
Go deeper on ChiCTR1800015604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015604.